Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.artere.2020.11.004 http://scihub22266oqcxt.onion/10.1016/j.artere.2020.11.004 C7648510!7648510 !C7648510     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=C7648510 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       ?-/-? 2020 ; 32 (6 ): 278-81 Nephropedia Template TP {{tp|p=C7648510 |t=2020. Statins in COVID-19: Is there any foundation? |pdf=|usr=}}{{C7648510 }} gab.com Text Statins in COVID-19: Is there any foundation JO: ?-/-? http://www.kidney.de/pget.php?&tw=1&pmid=C7648510 #FOAvip Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causal agent of coronavirus disease 2019 (COVID-19). Acute respiratory distress syndrome is the main cause of death from COVID-19 and occurs due to an exaggerated inflammatory response that causes the release of pro-inflammatory cytokines such as interleukins and tumor necrosis factor-alpha (TNF-?). Statins are lipid lowering drugs with pleiotropic effects. They have shown benefit in the management of inflammatory and autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis. Furthermore, due to their immunomodulatory properties, they have been used in the treatment of various infectious diseases such as community-acquired pneumonia and influenza. In this review we analyze the pathophysiological foundations that support the use of statins as an adjunctive treatment in patients with COVID-19. Twit Text FOAVip Statins in COVID-19: Is there any foundation ?????-/-? http://www.kidney.de/pget.php?&tw=1&pmid=C7648510 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=C7648510 #FOAvip English Wikipedia <ref>{{Cite pmid|C7648510 }}</ref> Statins in COVID-19: Is there any foundation? #MMPMIDC7648510 Lima Martínez MM ; Contreras MA ; Marín W ; D?Marco L ?-/-? 2020[Nov]; 32 (6 ): 278-81 PMIDC7648510 show ga Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causal agent of coronavirus disease 2019 (COVID-19). Acute respiratory distress syndrome is the main cause of death from COVID-19 and occurs due to an exaggerated inflammatory response that causes the release of pro-inflammatory cytokines such as interleukins and tumor necrosis factor-alpha (TNF-?). Statins are lipid lowering drugs with pleiotropic effects. They have shown benefit in the management of inflammatory and autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis. Furthermore, due to their immunomodulatory properties, they have been used in the treatment of various infectious diseases such as community-acquired pneumonia and influenza. In this review we analyze the pathophysiological foundations that support the use of statins as an adjunctive treatment in patients with COVID-19. ?Statins in COVID-19: Is there any foundation? (epmc).pdf DeepDyve Pubget Overpricing